{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:06:26Z","timestamp":1770833186058,"version":"3.50.1"},"reference-count":57,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB\u2010F204"],"award-info":[{"award-number":["SFB\u2010F204"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P\u201011946\u2010Med"],"award-info":[{"award-number":["P\u201011946\u2010Med"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["\u00d6NB\u20106156"],"award-info":[{"award-number":["\u00d6NB\u20106156"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012163","name":"Universit\u00e4t Innsbruck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012163","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[1999,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    The histone deacetylase inhibitor and potential anti\u2010cancer drug sodium butyrate is a general inducer of growth arrest, differentiation, and in certain cell types, apoptosis. In human CCRF\u2010CEM, acute T lymphoblastic leukemia cells, butyrate, and other histone deacetylase inhibitors caused G2\/M cell cycle arrest as well as apoptotic cell death. Forced G0\/G1 arrest by tetracycline\u2010regulated expression of transgenic\n                    <jats:italic>p16\/INK4A<\/jats:italic>\n                    protected the cells from butyrate\u2010induced cell death without affecting the extent of histone hyperacetylation, suggesting that the latter may be necessary, but not sufficient, for cell death induction. Nuclear apoptosis, but not G2\/M arrest, was delayed but not prevented by the tripeptide broad\u2010range caspase inhibitor benzyloxycarbonyl\u2010Val\u2010Ala\u2010Asp\u00b7fluoromethylketone (zVAD) and, to a lesser extent, by the tetrapeptide \u2018effector caspase\u2019 inhibitors benzyloxycarbonyl\u2010Asp\u2010Glu\u2010Val\u2010Asp\u00b7fluoromethylketone (DEVD) and benzyloxycarbonyl\u2010Val\u2010Glu\u2010Ile\u2010Asp\u2010fluoromethyl\u2010ketone (VEID); however, the viral protein inhibitor of \u2018inducer caspases\u2019, crmA, had no effect. Bcl\u20102 overexpression partially protected stably transfected CCRF\u2010CEM sublines from butyrate\u2010induced apoptosis, but showed no effect on butyrate\u2010induced growth inhibition, further distinguishing these two butyrate effects. c\n                    <jats:italic>\u2010myc<\/jats:italic>\n                    , constitutively expressed in CCRF\u2010CEM cells, was down\u2010regulated by butyrate, but this was not causative for cell death. On the contrary, tetracycline\u2010induced transgenic c\u2010\n                    <jats:italic>myc<\/jats:italic>\n                    sensitized stably transfected CCRF\u2010CEM derivatives to butyrate\u2010induced cell death.\u2014Bernhard, D., Ausserlechner, M. J., Tonko, M., L\u00f6ffler, M., Hartmann, B. L., Csordas, A., Kofler, R. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.\n                    <jats:italic>FASEB J<\/jats:italic>\n                    . 13, 1991\u20132001 (1999)\n                  <\/jats:p>","DOI":"10.1096\/fasebj.13.14.1991","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T04:39:04Z","timestamp":1516855144000},"page":"1991-2001","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts"],"prefix":"10.1096","volume":"13","author":[{"given":"David","family":"Bernhard","sequence":"first","affiliation":[{"name":"Institute for General and Experimental Pathology Division of Molecular Pathophysiology  Innsbruck Austria A\u20106020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Ausserlechner","sequence":"additional","affiliation":[{"name":"Institute for General and Experimental Pathology Division of Molecular Pathophysiology  Innsbruck Austria A\u20106020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Tonko","sequence":"additional","affiliation":[{"name":"Institute for General and Experimental Pathology Division of Molecular Pathophysiology  Innsbruck Austria A\u20106020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"L\u00f6ffler","sequence":"additional","affiliation":[{"name":"Institute for General and Experimental Pathology Division of Molecular Pathophysiology  Innsbruck Austria A\u20106020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd L.","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Institute for General and Experimental Pathology Division of Molecular Pathophysiology  Innsbruck Austria A\u20106020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Csordas","sequence":"additional","affiliation":[{"name":"Institute of Medical Chemistry and Biochemistry University of Innsbruck Medical School  Innsbruck Austria A\u20106020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Kofler","sequence":"additional","affiliation":[{"name":"Institute for General and Experimental Pathology Division of Molecular Pathophysiology  Innsbruck Austria A\u20106020"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1999,11]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"105","volume-title":"Role of Gut Bacteria in Human Toxicology and Pharmacology","author":"Csordas A.","year":"1995"},{"key":"e_1_2_6_3_1","first-page":"275","volume-title":"Physiology and Clinical Aspects of Short\u2010chain Fatty Acids","author":"Kruh J.","year":"1995"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910600322"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"20466","DOI":"10.1016\/S0021-9258(20)80749-2","article-title":"Sodium butyrate causes an increase in the block to transcriptional elongation in the c\u2010myc gene in SW837 rectal carcinoma cells","volume":"268","author":"Heruth D. P.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400345"},{"key":"e_1_2_6_7_1","first-page":"311","article-title":"Bcl\u20102 expression regulates sodium butyrate\u2010induced apoptosis in human MCF\u20107 breast cancer cells","volume":"7","author":"Mandal M.","year":"1996","journal-title":"Cell Growth & Differ."},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199806000-00016"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401031"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1997.3725"},{"key":"e_1_2_6_11_1","first-page":"1713","article-title":"Alterations in pim\u20101 and c\u2010myc expression associated with butyrate\u2010induced growth factor dependence in autonomous rat NB2 lymphoma cells","volume":"7","author":"Buckley A. R.","year":"1996","journal-title":"Cell Growth & Differ."},{"key":"e_1_2_6_12_1","first-page":"629","article-title":"Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors","volume":"4","author":"Conley B. A.","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830101)51:1<9::AID-CNCR2820510104>3.0.CO;2-4"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90109-X"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.151"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/268462a0"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)34804-4"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)44885-X"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81059-4"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/38664"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80211-1"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.5.599"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301143280202"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.5.2075"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.12.6791"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.35.22199"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201304"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<898::AID-IJC30>3.0.CO;2-2"},{"key":"e_1_2_6_29_1","first-page":"3785","article-title":"Characterization of a glucocorticoid\u2010sensitive human lymphoid cell line","volume":"37","author":"Norman M. R.","year":"1977","journal-title":"Cancer Res."},{"key":"e_1_2_6_30_1","first-page":"348","article-title":"Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid\u2010induced apoptosis in a human acute leukemic cell line","volume":"55","author":"Strasser\u2010Wozak E. M. C.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(96)01496-2"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202339"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202820"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.12.5547"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7792603"},{"key":"e_1_2_6_36_1","unstructured":"Ausserlechner M. J. Obexer P. Hartmann B. L. Geley S. andKofler R.(1999)Tetracycline\u2010regulated p16\/INK4A induces G1\/Go arrest and differentiation in human p16\/INK4A\u2010deficient malignant T lymphoblasts. In preparation"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-679X(08)61145-0"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90198-O"},{"key":"e_1_2_6_39_1","first-page":"107","volume-title":"Techniques in Apoptosis","author":"Martin S. J.","year":"1996"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1994.1184"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201399"},{"key":"e_1_2_6_42_1","first-page":"5033","article-title":"Resistance to glucocorticoid\u2010induced apoptosis in human T\u2010cell acute lymphoblastic leukemia CEM\u2010C1 cells is due to insufficient glucocorticoid receptor expression","volume":"56","author":"Geley S.","year":"1996","journal-title":"Cancer Res."},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/340066a0"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00276a013"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(96)00904-5"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80430-4"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81334-3"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(97)01107-9"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.18.10377"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.12.7797"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400268"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.29.17907"},{"key":"e_1_2_6_53_1","first-page":"3697","article-title":"Induction of caspase\u20103 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial cytochrome c\u2010dependent pathway","volume":"57","author":"Medina V.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.60.1.575"},{"key":"e_1_2_6_55_1","first-page":"1436","article-title":"Involvement of CDKN2 (p16INK4A\/MTS1) and p15\n                  INK4B\/MTS2 in human leukemias and lymphomas","volume":"55","author":"Otsuki T.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(96)01284-7"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90188-0"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1317"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.13.14.1991","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fasebj.13.14.1991","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.13.14.1991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:57:47Z","timestamp":1761681467000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fasebj.13.14.1991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":57,"journal-issue":{"issue":"14","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["10.1096\/fasebj.13.14.1991"],"URL":"https:\/\/doi.org\/10.1096\/fasebj.13.14.1991","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11]]},"assertion":[{"value":"1998-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}